Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus

Scandinavian Journal of Immunology

Volumn 48, Issue 2, 1998, Pages 196-200

  Crispin, J C ^a   Martinez A ^a   De Pablo, P ^a   Velasquillo, C ^a   Alcocer Varela, J ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN;

ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0031813801     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00366.x     Document Type: Article

References (20)

1. Alarcón-Segovia D, Alcocer-Varela J, Díaz-Jouanen E. The connective tissue diseases as disorders of immune regulation. Clin Rheum Dis 1985;11:451-69.
2. Mohan C, Datta SK. Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 1995;77:209-20.
3. Laffón A, Alcocer-Varela J, Alarcón-Segovia D. Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases. Rheumatol Int 1983;3:117-28.
4. Alcocer-Varela J, Alarcón-Riquelme M, Laffón A, Sánchez-Madrid F. Alarcón-Segovia D. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. J Autoimmunity 1991;4:935-45.
5. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science 1989;243:355-61.
6. Hamann J, Fiebig H, Strauss M. Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. J Immunol 1993;150:4920-7.
7. Risso A, Smilovich D, Capra MC et al. CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. J Immunol 1991;146:4105-14.
8. Cebrián M, Yagüe E, Rincón M, López-Botet M, de Landázuri MO, Sánchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 1988;168:1621-37.
9. ++) and stimulation of protein kinase C. J Immunol 1989;142:1854-60.
10. D'Ambrosio D, Cantrell DA, Frati L, Santoni A, Testi R. Involvement of p21ras activation in T cell CD69 expression. Eur J Immunol 1994;24:616-20.
11. Taylor-Fishwick DA, Siegel JN. Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells. Eur J Immunol 1995;25:3215-21.
12. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Guzmán J, Cardiel MH, Arce-Salinas A, Sánchez-Guerrero J, Alarcón-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992;19:1551-8.
14. Maino VC, Suni MA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 1995;20:127-33.
15. Llorente L, Richaud-Patin Y, Fior R et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994;37:1647-55.
16. Lorenz HM, Grünke M, Hieronymus T et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997;40:306-17.
17. + during activation of lymphocytes from patients with systemic lupus erythematosus. Lupus 1997;6:48-56.
18. Su C-C, Shau W-Y, Wang C-R, Chuang C-Y, Chen C-Y. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity. Lupus 1997;6:449-54.
19. Fernández-Gutiérrez B, Hernández-García C, Bañares AA, Jover JA. Characterization and regulation of CD69 expression on rheumatoid arthritis synovial fluid T cells. J Rheumatol 1995;22:413-20.
20. + synovial fluid gd T cells in juvenile rheumatoid arthritis patients express the very early activation marker CD69, but carry the high molecular weight isoform of the leucocyte common antigen (CD45RA). Clin Exp Immunol 1993;91:202-6.